Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 1.055
-0.020 (-1.86%)
At close: Nov 26, 2025
Orthocell Market Cap
Orthocell has a market cap or net worth of 286 million as of November 26, 2025. Its market cap has increased by 86.89% in one year.
Market Cap
286.00M
Enterprise Value
257.96M
Revenue
7.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.06
Market Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 286.00M, an increase of 862.96%. That is a compound annual growth rate of 22.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 286.00M | -11.95% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | 83.15M | -7.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 87.96B |
| Pro Medicus | 27.18B |
| Cochlear | 18.26B |
| Sonic Healthcare | 11.46B |
| Ramsay Health Care | 8.27B |
| Ansell | 5.23B |
| Telix Pharmaceuticals | 5.09B |
| Mesoblast | 3.05B |